[{"NetIncomeLoss_1_Q2_USD":-80010000.0,"OperatingLeaseExpense_2_Q2_USD":3400000.0,"AssetsCurrent_0_Q2_USD":1489089000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":5942000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":-18571000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":-35915000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":6345000.0,"Depreciation_1_Q2_USD":6907000.0,"Depreciation_2_Q2_USD":14072000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-376275000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":166500000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":275601000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-1886000.0,"InterestPaidNet_2_Q2_USD":30068000.0,"TreasuryStockCommonShares_0_Q2_shares":384366.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":28708000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":39618000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":415545000.0,"OperatingLeaseExpense_1_Q2_USD":1800000.0,"LongTermDebt_0_Q2_USD":1176822000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":470107000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":222332000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":564643000.0,"DebtConversionConvertedInstrumentAmount1_2_Q2_USD":207044000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":15.98,"OperatingLeaseRightOfUseAsset_0_Q2_USD":37100000.0,"ShareBasedCompensation_2_Q2_USD":83478000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":344000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":19000.0,"Assets_0_Q2_USD":4538191000.0,"LiabilitiesNoncurrent_0_Q2_USD":1191683000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":22969000.0,"IncomeTaxesPaidNet_2_Q2_USD":597000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":7118000.0,"TreasuryStockValue_0_Q2_USD":4585000.0,"GoodwillImpairedAccumulatedImpairmentLoss_0_Q2_USD":0.0,"ResearchAndDevelopmentInProcess_2_Q2_USD":47517000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":121515000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":218931000.0,"DebtInstrumentUnamortizedDiscount_0_Q2_USD":29226000.0,"CommonStockSharesIssued_0_Q2_shares":199991807.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommitmentsAndContingencies_0_Q2_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":191426864.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q2_USD":205650000.0,"CommonStockValue_0_Q2_USD":20000.0,"NumberOfReportableSegments_2_Q2_Segment":2.0,"IncomeTaxExpenseBenefit_1_Q2_USD":82964000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":63938000.0,"AccountsReceivableNetCurrent_0_Q2_USD":543755000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":1074000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":632000.0,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":-17254000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":81505000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":58000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":1189199000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":69038000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":20.62,"ResearchAndDevelopmentExpense_1_Q2_USD":81068000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":108277000.0,"BusinessCombinationAcquisitionRelatedCosts_1_Q2_USD":46988000.0,"InterestPayableCurrent_0_Q2_USD":15821000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":6487000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":139396000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q2_USD":283000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":192705535.0,"AccruedRoyaltiesCurrent_0_Q2_USD":32634000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":20.66,"IncreaseDecreaseInOtherOperatingCapitalNet_2_Q2_USD":-16586000.0,"OperatingLeaseLiability_0_Q2_USD":48862000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":3067586000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":44200000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":718062000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":247400000.0,"OtherAssetsNoncurrent_0_Q2_USD":40889000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":125324000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":83555000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-79666000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-93582000.0,"IncreaseDecreaseInInventories_2_Q2_USD":12343000.0,"ConvertibleNotesPayableCurrent_0_Q2_USD":174504000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-19143000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":1059000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":66749000.0,"PaymentsToAcquireBusinessesGross_2_Q2_USD":262305000.0,"GoodwillGross_0_Q2_USD":413700000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":20176000.0,"AccountsPayableCurrent_0_Q2_USD":106015000.0,"LiabilitiesCurrent_0_Q2_USD":984656000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":14422000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":37008000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":344000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":19000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":27057000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":53009000.0,"InterestIncomeExpenseNet_1_Q2_USD":-18571000.0,"InterestIncomeExpenseNet_2_Q2_USD":-35915000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":23.08,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_Q2_shares":25257.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-29663000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":2954000.0,"Goodwill_0_Q2_USD":413669000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":38890000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":246227000.0,"NonoperatingIncomeExpense_2_Q2_USD":-51036000.0,"NonoperatingIncomeExpense_1_Q2_USD":-34910000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2_Q2_USD":7979000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":157548000.0,"NetIncomeLoss_2_Q2_USD":-93601000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":138801000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":265146000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":2912000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q2_USD":779784000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":99164000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":1891100000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":7979000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":245610000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":1601809.0,"IncreaseDecreaseInDeferredIncomeTaxes_2_Q2_USD":4561000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.071,"GrossProfit_1_Q2_USD":341264000.0,"GrossProfit_2_Q2_USD":599757000.0,"AccruedIncomeTaxesCurrent_0_Q2_USD":66418000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":24041000.0,"LongTermDebtNoncurrent_0_Q2_USD":1002318000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":25887000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":721687000.0,"CommonStockSharesOutstanding_0_Q2_shares":199607441.0,"AssetImpairmentCharges_1_Q2_USD":1072000.0,"AssetImpairmentCharges_2_Q2_USD":1072000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":177691000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":54747.0,"ForeignCurrencyExchangeRateTranslation1_0_Q2_USD\/EUR":1.1236,"AllocatedShareBasedCompensationExpense_1_Q2_USD":27057000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":83478000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":85982000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":4538191000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":16.19,"OperatingLeaseLiabilityCurrent_0_Q2_USD":4700000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":3080299000.0,"OperatingIncomeLoss_1_Q2_USD":37864000.0,"OperatingIncomeLoss_2_Q2_USD":21373000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":462779000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":818688000.0,"CommonStockSharesAuthorized_0_Q2_shares":600000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":20410000.0,"DeferredFinanceCostsNet_0_Q2_USD":4934000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":5869000.0,"InventoryNet_0_Q2_USD":66099000.0,"BusinessCombinationAcquisitionRelatedCosts_2_Q2_USD":47272000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":127901000.0,"OperatingExpenses_1_Q2_USD":303400000.0,"SeniorLongTermNotes_0_Q2_USD":1002318000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":135125000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-358352000.0,"DebtInstrumentConvertibleConversionPrice1_0_Q2_USD":28.66,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-699283000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":7593802.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":7882389.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":10817000.0,"OperatingExpenses_2_Q2_USD":578384000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q2_USD":244178000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":119970000.0,"AdvancesOnInventoryPurchases_0_Q2_USD":48514000.0,"StockholdersEquity_0_Q2_USD":2361852000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":90201000.0,"ProfitLoss_2_Q2_USD":-93601000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.42,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.49,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q2_USD":3625000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":1210982000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":39513000.0,"Ticker":"HZNP","CIK":"1492426","name":"HORIZON THERAPEUTICS PUBLIC LTD CO","OfficialName":"Horizon Therapeutics Public Limited Company Ordinary Shares","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"26299872538.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200805"}]